PRIA Continues its Support of LSI in 2026

Nancy Bax • November 6, 2025

Continuing and Strengthening our Relationship with a Vital Industry Event

For 2026, PRIA Healthcare continues to be a Supporting Sponsor of LSI’s international events.  MedTech market access, commercialization and investment all take root at these invaluable conferences. PRIA is honored to meet the world's most vibrant innovators, investors, and industry leaders, and to discuss how we can help groundbreaking technologies reach patients who need them most.


Our team, including Jeffrey Sirek, Tonya Dowd, and Stephanie DeFelice, look forward to attending and having meaningful conversations, about navigating the complexities of market access, reimbursement, and commercialization.


If you’re joining us at LSI in 2026, we invite you to connect with us via the partnering app.



See You in Dana Point and Barcelona!

Tonya Dowd, MPH, Executive Vice President, Reimbursement, Health Economics, and Market Access (RHEMA) and Corporate Development shared her insights on the importance of early strategic planning on the panel "Unseen Risks, Unlocked Value: Quantifying Regulatory and Reimbursement Barriers in MedTech Investment" at LSI Europe '25.

Tonya Dowd on the informative panel,

Click the Icon below to share this with your network

Regulatory Meets Reimbursement: What MedTech Innovators Need to Know About FDA Breakthrough & Beyond
June 19, 2026
Regulatory Meets Reimbursement: What MedTech Innovators Need to Know About FDA Breakthrough and Beyond
Stop Guessing What FDA Wants by Sam Murray
By Sam Murray June 4, 2026
Stop Guessing What FDA Wants
You Got Your 510(k). Now What?
By Suzy Engwall May 28, 2026
You Got Your 510(k). Now What?
Right Sizing Your Quality System by Sam Murray
By Sam Murray, Head of Regulatory & Quality May 21, 2026
Right Sizing Your Quality System
Cleared for takeoff: Insights from a Medtech First Officer
By Suzy Engwall May 19, 2026
Five Mistakes MedTech StartUps Make Before Their First VAC Meeting
Using Regulatory as a Strategy and Not a Milestone
By Sam Murray, PRIA May 14, 2026
Using Regulatory as a Strategy and Not a Milestone
Reading the Water: Navigating What Matters in Regulatory and Quality  - Sam Murray, PRIA
By Sam Murray, Head of Regulatory & Quality May 6, 2026
An informative article series from PRIA Healthcare's Head of Regulatory and Quality, Sam Murray
Medical device strategy CMS/FDA RAPID program
April 24, 2026
PRIA examines the impact of the RAPID program, accelerating Medicare access for Breakthrough Devices by aligning FDA approval & CMS coverage, earlier, on innovators.
MedTech Clinical Evidence Strategy
By PRIA Healthcare April 20, 2026
PRIA's experts on reimbursement and regulatory issues weigh in on CMS's proposed NTAP change, and what it may mean for MedTech innovations.
PRIA Healthcare welcomes Sam Murray as Head of Regulatory and Quality Services
March 10, 2026
PRIA Healthcare is thrilled to announce that Sam Murray has joined PRIA as our Head of Regulatory and Quality. Sam brings more than a decade of experience doing exactly that kind of high-stakes, high-impact regulatory work across medical devices, diagnostics, combination products, and software-enabled technologies.
PRIA a strategic and execution partner for reimbursement and market access
By Tonya Dowd, MPH, Executive Vice President, Reimbursement, Health Economics, Market Access and Corporate Development February 23, 2026
MedTech reimbursement and market access, core drivers of valuation, acquisition potential, and long-term viability, should be developed in sync with your regulatory strategy
PRIA's H2 Newsletter - PRIA Pages
By Nancy Bax December 23, 2025
PRIA's Second Quarter in Review